These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Monoamine oxidase inhibitors. Lippmann S. Am Fam Physician; 1986 Jul 24; 34(1):113-9. PubMed ID: 3728254 [Abstract] [Full Text] [Related]
14. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors. Kennedy SH. J Psychiatry Neurosci; 1997 Mar 24; 22(2):127-31. PubMed ID: 9074307 [Abstract] [Full Text] [Related]
16. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression. Tulen JH, Volkers AC, van den Broek WW, Bruijn JA. J Clin Psychopharmacol; 2006 Oct 24; 26(5):542-4. PubMed ID: 16974207 [No Abstract] [Full Text] [Related]
17. Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants. Nolen WA, Haffmans PM, Bouvy PF, Duivenvoorden HJ. J Affect Disord; 1993 Jul 24; 28(3):189-97. PubMed ID: 8408980 [Abstract] [Full Text] [Related]
18. The importance of dosage in prescribing antidepressants. Quitkin FM. Br J Psychiatry; 1985 Dec 24; 147():593-7. PubMed ID: 3913485 [Abstract] [Full Text] [Related]
19. A 3-year follow-up of a group of treatment-resistant depressed patients with a MAOI/tricyclic combination. Berlanga C, Ortega-Soto HA. J Affect Disord; 1995 Jun 08; 34(3):187-92. PubMed ID: 7560546 [Abstract] [Full Text] [Related]
20. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression. Feighner JP, Herbstein J, Damlouji N. J Clin Psychiatry; 1985 Jun 08; 46(6):206-9. PubMed ID: 3997787 [Abstract] [Full Text] [Related] Page: [Next] [New Search]